(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 25.96% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Fortress Biotech's revenue in 2024 is $85,114,000.On average, 2 Wall Street analysts forecast FBIO's revenue for 2024 to be $1,617,488,011, with the lowest FBIO revenue forecast at $1,511,633,812, and the highest FBIO revenue forecast at $1,723,342,210. On average, 2 Wall Street analysts forecast FBIO's revenue for 2025 to be $2,600,448,311, with the lowest FBIO revenue forecast at $2,519,389,686, and the highest FBIO revenue forecast at $2,681,506,935.
In 2026, FBIO is forecast to generate $3,348,497,928 in revenue, with the lowest revenue forecast at $3,146,747,592 and the highest revenue forecast at $3,550,248,264.